102 related articles for article (PubMed ID: 18633254)
1. [A pilot study of rebamipide-gargle for chemoradiotherapy-induced mucositis in oral cancer patients].
Yasuda T; Chiba H; Satomi T; Matsuo A; Kaneko T; Miyamatsu H
Gan To Kagaku Ryoho; 2008 Jul; 35(7):1157-61. PubMed ID: 18633254
[TBL] [Abstract][Full Text] [Related]
2. Rebamipide gargle in preventive management of chemo-radiotherapy induced oral mucositis.
Chaitanya B; Pai KM; Yathiraj PH; Fernandes D; Chhaparwal Y
Oral Oncol; 2017 Sep; 72():179-182. PubMed ID: 28797456
[TBL] [Abstract][Full Text] [Related]
3. [Pilot study on clinical effects of rebamipide gargle against oral mucositis induced by fluoropyrimidines].
Kabeya M; Ina K; Yuasa S; Kikuchi F; Tajiri C; Kato T; Hibi S; Minagawa Y; Furuta R; Kayukawa S; Kataoka T; Kawai M
Gan To Kagaku Ryoho; 2011 Jul; 38(7):1133-6. PubMed ID: 21772097
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy of Rebamipide Gargle against Chemotherapy-induced Oral Mucositis].
Shinohara A; Nakamura M; Onikubo T; Nakamura K
Yakugaku Zasshi; 2015; 135(8):937-41. PubMed ID: 26234350
[TBL] [Abstract][Full Text] [Related]
5. [Investigation of how to prevent mucositis induced by chemoradiotherapy].
Tosaka C; Tajima H; Inoue T; Moya M; Kobayashi M; Miura K; Tada Y; Masubuchi T; Hushimi C; Kamata S
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1647-51. PubMed ID: 21996960
[TBL] [Abstract][Full Text] [Related]
6. Rebamipide gargle and benzydamine gargle in prevention and management of chemo-radiotherapy and radiotherapy-induced oral mucositis in head and neck cancer patients (randomized clinical trial).
Elsaadany B; Anayb SM; Mashhour K; Yossif M; Zahran F
BMC Oral Health; 2024 Jun; 24(1):645. PubMed ID: 38824583
[TBL] [Abstract][Full Text] [Related]
7. [The effects of Rebamipide and Polaprezinc mouthwash and uptake on mucositis induced by chemotherapy].
Fukuhara K; Terakura M; Katsuragi K; Kodama S; Morisya Y; Hayaishi Y; Nakanishi C
Gan To Kagaku Ryoho; 2011 Dec; 38(13):2603-6. PubMed ID: 22189226
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of rebamipide liquid for chemoradiotherapy-induced oral mucositis in patients with head and neck cancer: a multicenter, randomized, double-blind, placebo-controlled, parallel-group phase II study.
Yokota T; Ogawa T; Takahashi S; Okami K; Fujii T; Tanaka K; Iwae S; Ota I; Ueda T; Monden N; Matsuura K; Kojima H; Ueda S; Sasaki K; Fujimoto Y; Hasegawa Y; Beppu T; Nishimori H; Hirano S; Naka Y; Matsushima Y; Fujii M; Tahara M
BMC Cancer; 2017 May; 17(1):314. PubMed ID: 28476132
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effect of rebamipide for oral mucositis associated with FEC therapy for breast cancer].
Enami A; Masuda N; Yamamura J; Mizutani M; Yasojima H; Shikata A; Masaoka M; Takada S; Bamba N; Yamamoto M; Abe M; Makihara K
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1407-12. PubMed ID: 25434444
[TBL] [Abstract][Full Text] [Related]
10. Rebamipide does not interfere with the antitumor effect of radiotherapy or chemotherapy in human oral tumor-bearing nude mice.
Shibamori M; Sato M; Uematsu N; Nakashima T; Sato A; Yamamura Y; Sasabe H; Umehara K; Sakurai K
J Pharmacol Sci; 2015 Sep; 129(1):18-25. PubMed ID: 26320673
[TBL] [Abstract][Full Text] [Related]
11. Preventive effect of rebamipide gargle on chemoradiotherpy-induced oral mucositis in patients with oral cancer: a pilot study.
Yasuda T; Chiba H; Satomi T; Matsuo A; Kaneko T; Chikazu D; Miyamatsu H
J Oral Maxillofac Res; 2012; 2(4):e3. PubMed ID: 24422000
[TBL] [Abstract][Full Text] [Related]
12. Rebamipide attenuates 5-Fluorouracil-induced small intestinal mucositis in a mouse model.
Kim HJ; Kim JH; Moon W; Park J; Park SJ; Song GA; Han SH; Lee JH
Biol Pharm Bull; 2015; 38(2):179-83. PubMed ID: 25747976
[TBL] [Abstract][Full Text] [Related]
13. Intra-oral administration of rebamipide liquid prevents tongue injuries induced by X-ray irradiation in rats.
Nakashima T; Uematsu N; Sakurai K
Support Care Cancer; 2017 Jul; 25(7):2205-2213. PubMed ID: 28204991
[TBL] [Abstract][Full Text] [Related]
14. Novel submicronized rebamipide liquid with moderate viscosity: significant effects on oral mucositis in animal models.
Nakashima T; Sako N; Matsuda T; Uematsu N; Sakurai K; Ishida T
Biol Pharm Bull; 2014; 37(4):671-8. PubMed ID: 24694614
[TBL] [Abstract][Full Text] [Related]
15. Effects of a Rebamipide Mouthwash on Stomatitis Caused by Cancer Chemotherapy-Evaluation of the Efficacy by Patients Themselves.
Ishii N; Kawano Y; Sakai H; Hayashi S; Akizuki N; Komoda M; Hanawa T
Yakugaku Zasshi; 2017 Aug; 137(8):1027-1034. PubMed ID: 28496016
[TBL] [Abstract][Full Text] [Related]
16. The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer.
Ueno T; Zenda S; Konishi T; Yurikusa T; Shibasaki Y; Nagamoto H; Fujii M
Int J Clin Oncol; 2019 Mar; 24(3):241-247. PubMed ID: 30426268
[TBL] [Abstract][Full Text] [Related]
17. Phenylbutyrate mouthwash mitigates oral mucositis during radiotherapy or chemoradiotherapy in patients with head-and-neck cancer.
Yen SH; Wang LW; Lin YH; Jen YM; Chung YL
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1463-70. PubMed ID: 21840136
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis of oral mucositis associated with chemoradiotherapy for oral carcinoma by Azelastine hydrochloride (Azelastine) with other antioxidants.
Osaki T; Ueta E; Yoneda K; Hirota J; Yamamoto T
Head Neck; 1994; 16(4):331-9. PubMed ID: 8056578
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of elemental diet on prevention for chemoradiotherapy-induced oral mucositis in patients with oral squamous cell carcinoma.
Harada K; Ferdous T; Horinaga D; Uchida K; Mano T; Mishima K; Park S; Hanazawa H; Takahashi S; Okita A; Fukunaga M; Maruta J; Kami N; Shibuya K; Ueyama Y
Support Care Cancer; 2016 Feb; 24(2):953-959. PubMed ID: 26248650
[TBL] [Abstract][Full Text] [Related]
20. Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.
Mantovani G; Massa E; Astara G; Murgia V; Gramignano G; Lusso MR; Camboni P; Ferreli L; Mocci M; Perboni S; Mura L; Madeddu C; Macciò A
Oncol Rep; 2003; 10(1):197-206. PubMed ID: 12469169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
